List of ICD-9 codes 140–239: neoplasms

2. Neoplasms (140–239) 1
- Malignant neoplasm of lip, oral cavity, and pharynx (140–149) 1.1
- Malignant neoplasm of digestive organs and peritoneum (150–159) 1.2
- Malignant neoplasm of respiratory and intrathoracic organs (160–165) 1.3
- Malignant neoplasm of bone, connective tissue, skin, and breast (170–175) 1.4
- Kaposi's sarcoma (176–176) 1.5
- Malignant neoplasm of genitourinary organs (179–189) 1.6
- Malignant neoplasm of other and unspecified sites (190–199) 1.7
- Malignant neoplasm of lymphatic and hematopoietic tissue (200–208) 1.8
- Neuroendocrine tumors (209–209) 1.9
- Benign neoplasms (210–229) 1.10
- Carcinoma in situ (230–234) 1.11
- Neoplasms of uncertain behavior (235–238) 1.12
- Neoplasms of unspecified nature (239–239) 1.13
See also 2

2. Neoplasms (140–239)

Excellent overview here of primary/secondary/in situ/benign

Kaposi's sarcoma (176–176)

(176) Kaposi's sarcoma
- (176.0) Kaposi's sarcoma skin
- (176.1) Kaposi's sarcoma soft tissue
- (176.2) Kaposi's sarcoma palate
- (176.3) Kaposi's sarcoma gastrointestinal sites
- (176.4) Kaposi's sarcoma
- (176.5) Kaposi's sarcoma lymph nodes
- (176.8) Kaposi's sarcoma other specified sites
- (176.9) Kaposi's sarcoma unspecified site

Malignant neoplasm of genitourinary organs (179–189)

(179) Malignant neoplasm of uterus, part unspecified
(180) Malignant neoplasm of cervix uteri
(181) Malignant neoplasm of placenta
(182) Malignant neoplasm of body of uterus
- (182.0) Corpus uteri, except isthmus
  - Endometrial cancer
(183) Malignant neoplasm of ovary and other uterine adnexa
(184) female genital organs
(185) Malignant neoplasm of prostate
(186) Malignant neoplasm of testis
(187) male genital organs
(188) Malignant neoplasm of bladder
(189) urinary organs
- (189.0) Kidney, except pelvis
  - Renal cell carcinoma

Malignant neoplasm of other and unspecified sites (190–199)

(190) Malignant neoplasm of eye
(191) Malignant neoplasm of brain
(192) Malignant neoplasm of other and unspecified parts of nervous system
- (192.0) Cranial nerve
- (192.1) Cerebral meninges
  - Meningioma
- (192.2) Spinal cord
- (192.3) Spinal meninges
(193) Malignant neoplasm of thyroid gland
(194) Malignant neoplasm of other endocrine glands and related structures
(195) Malignant neoplasm of other and ill-defined sites
(196) Secondary and unspecified malignant neoplasm of lymph nodes
(197) Secondary malignant neoplasm of respiratory and digestive systems
(198) Secondary malignant neoplasm of other specified sites
(199) Malignant neoplasm without specification of site

Malignant neoplasm of lymphatic and hematopoietic tissue (200–208)

(200) Lymphosarcoma and reticulosarcoma
- (200.0) Reticulosarcoma
- (200.1) Lymphosarcoma
- (200.2) Burkitt's tumor or lymphoma
- (200.3) Marginal zone lymphoma
- (200.4) Mantle cell lymphoma
- (200.5) Primary central nervous system lymphoma
- (200.6) Anaplastic large cell lymphoma
- (200.7) Large cell lymphoma
- (200.8) Other named variants of lymphosarcoma and reticulosarcoma
(201) Hodgkin's disease
(202) Other malignant neoplasms of lymphoid and histiocytic tissue
- (202.0) Nodular lymphoma
- (202.1) Mycosis fungoides
- (202.2) Sézary's disease
- (202.3) Malignant histiocytosis
- (202.4) Leukemic reticuloendotheliosis (commonly called hairy cell leukemia)
- (202.5) Letterer-Siwe disease
- (202.6) Malignant mast cell tumors
- (202.7) Peripheral T-cell lymphoma
- (202.8) Other lymphomas
- (202.9) Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue
(203) Multiple myeloma and immunoproliferative neoplasms
- (203.0) Multiple myeloma
(204) Lymphoid leukemia
- (204.0) Acute lymphoblastic leukemia
- (204.1) Chronic lymphocytic leukemia
(205) Myeloid leukemia
- (205.0) Acute myelogenous leukemia
- (205.1) Chronic myelogenous leukemia
(206) Monocytic leukemia
(207) Other specified leukemia
- (207.0) Acute erythremia and erythroleukemia
- (207.1) Chronic erythremia
- (207.2) Megakaryocytic leukemia
(208) Leukemia of unspecified cell type

Neuroendocrine tumors (209–209)

(209) Neuroendocrine tumors
- (209.0) Malignant carcinoid tumors of the small intestine
- (209.1) Malignant carcinoid tumors of the appendix, large intestine, and rectum
- (209.2) Malignant carcinoid tumors of other and unspecified sites
- (209.3) Malignant poorly differentiated neuroendocrine carcinoma
- (209.4) Benign carcinoid tumors of the small intestine
- (209.5) Benign carcinoid tumors of the appendix, large intestine, and rectum
- (209.6) Benign carcinoid tumors of other and unspecified sites

Benign neoplasms (210–229)

(210) Benign neoplasm of lip, oral cavity, and pharynx
(211) Benign neoplasm of other parts of digestive system
- (211.3) Colon
  - Familial adenomatous polyposis
(212) Benign neoplasm of respiratory and intrathoracic organs
- (212.0) Nasal cavities middle ear and accessory sinuses
- (212.1) Larynx
- (212.2) Trachea
- (212.3) Bronchus and lung
- (212.4) Pleura
- (212.5) Mediastinum
- (212.6) Thymus
- (212.7) Heart
  - Myxoma
  - Rhabdomyoma
(213) Benign neoplasm of bone and articular cartilage
- (213.9) Bone and articular cartilage, site unspecified
  - Chondroma
(214) Lipoma
(215) Other benign neoplasm of connective and other soft tissue
(216) Benign neoplasm of skin
- Melanocytic nevus
(217) Benign neoplasm of breast
(218) Uterine leiomyoma
(219) Other benign neoplasm of uterus
(220) Benign neoplasm of ovary
(221) female genital organs
(222) male genital organs
(223) urinary organs
(224) Benign neoplasm of eye
(225) Benign neoplasm of brain and other parts of nervous system
(226) Benign neoplasm of thyroid glands
(227) Benign neoplasm of other endocrine glands and related structures
(228) Hemangioma and lymphangioma, any site
- (228.0) Hemangioma, any site
- (228.1) Lymphangioma, any site
(229) Benign neoplasm of other and unspecified sites

Carcinoma in situ (230–234)

(230) digestive organs
(231) Carcinoma in situ of respiratory system
(232) Carcinoma in situ of skin
(233) Carcinoma in situ of breast and genitourinary system
(234) Carcinoma in situ of other and unspecified sites

Neoplasms of uncertain behavior (235–238)

(235) Neoplasm of uncertain behavior of digestive and respiratory systems
(236) genitourinary organs
(237) Neoplasm of uncertain behavior of endocrine glands and nervous system
- (237.0) Pituitary gland and craniopharyngeal duct
  - Pituitary adenoma
- (237.7) Neurofibromatosis
(238) Neoplasm of uncertain behavior of other and unspecified sites and tissues
- (238.4) Polycythemia vera

Neoplasms of unspecified nature (239–239)

(239) Neoplasms of unspecified nature
- (239.2) Skin, soft tissue neoplasm, unspecified

Benign tumors	Hyperplasia Cyst Pseudocyst Hamartoma

Malignant progression	Dysplasia Carcinoma in situ Cancer Metastasis

Topography	Head/Neck (Oral, Nasopharyngeal) Digestive system Respiratory system Bone Skin Blood Urogenital Nervous system Endocrine system

Histology	Carcinoma Sarcoma Blastoma Papilloma Adenoma

Other	Precancerous condition Paraneoplastic syndrome

Staging/grading

Carcinogenesis

Misc.

Index of neoplasms and cancer

Description

Disease

Treatment	Drugs

Connective/soft tissue tumors and sarcomas (ICD-O 8800–9059) (C45–C49/D17–D21, 171/214–215)

Not otherwise specified

Connective tissue neoplasm

Fibromatous

Fibroma/fibrosarcoma:	Dermatofibrosarcoma protuberans Desmoplastic fibroma

Fibroma/fibromatosis:	Aggressive infantile fibromatosis Aponeurotic fibroma Collagenous fibroma Diffuse infantile fibromatosis Familial myxovascular fibromas Fibroma of tendon sheath Fibromatosis colli Infantile digital fibromatosis Juvenile hyaline fibromatosis Plantar fibromatosis Pleomorphic fibroma Oral submucous fibrosis

Histiocytoma/histiocytic sarcoma:	Benign fibrous histiocytoma Malignant fibrous histiocytoma Atypical fibroxanthoma Solitary fibrous tumor

Myxomatous

Fibroepithelial

Synovial-like

Lipomatous

Myomatous

general:	Myoma/myosarcoma

smooth muscle:	Leiomyoma/leiomyosarcoma

skeletal muscle:	Rhabdomyoma/rhabdomyosarcoma: Embryonal rhabdomyosarcoma Sarcoma botryoides Alveolar rhabdomyosarcoma

Leiomyoma Angioleiomyoma Angiolipoleiomyoma Genital leiomyoma Leiomyosarcoma Multiple cutaneous and uterine leiomyomatosis syndrome Multiple cutaneous leiomyoma Neural fibrolipoma Solitary cutaneous leiomyoma STUMP

Complex mixed and stromal

Mesothelial

Index of muscle

Description

Disease

Treatment	Drugs

Vascular tissue neoplasm (ICD-O 9120–9179) (C49+C46/D18, 171+176/215)

Blood

Lymphatic

Either

Index of the circulatory system

Description	Arteries Veins

Disease

Treatment	Drugs

179–184/218–221)

Adnexa

Ovaries

Glandular and epithelial/
surface epithelial-
stromal tumor

CMS:	Ovarian serous cystadenoma Mucinous cystadenoma Cystadenocarcinoma Papillary serous cystadenocarcinoma Krukenberg tumor

Endometrioid tumor Clear-cell ovarian carcinoma Brenner tumour

Sex cord-gonadal stromal

Germ cell

Fibroma

Meigs syndrome

Fallopian tube

Adenomatoid tumor

Uterus

Myometrium	Uterine fibroids/leiomyoma Leiomyosarcoma Adenomyoma

Endometrium	Endometrioid tumor Uterine papillary serous carcinoma Clear cell carcinoma Endometrial intraepithelial neoplasia

Cervix	Cervical intraepithelial neoplasia SCC Glassy cell carcinoma Villoglandular adenocarcinoma

Placenta	Choriocarcinoma Gestational trophoblastic disease

General	Uterine sarcoma Mixed Müllerian tumor

Vagina

Vulva

Index of reproductive medicine

Description	Anatomy

Disease	Infections Congenital Neoplasms and cancer Other

Treatment	Procedures Drugs hormones

185–187/222)

Internal

Testicles

Sex cord-
gonadal stromal

Sertoli-Leydig cell tumour
- Sertoli cell tumour
- Leydig cell tumour

Germ cell

G	Seminoma Spermatocytic seminoma Intratubular germ cell neoplasia

NG	Embryonal carcinoma Endodermal sinus tumor Gonadoblastoma Teratoma Choriocarcinoma Embryoma

Prostate

External

Penis	Carcinoma Extramammary Paget's disease Bowen's disease Bowenoid papulosis Erythroplasia of Queyrat Hirsuties coronae glandis

Index of reproductive medicine

Description	Anatomy

Disease	Infections Congenital Neoplasms and cancer Other

Treatment	Procedures Drugs hormones

Nervous tissue tumors/NS neoplasm/Neuroectodermal tumor (ICD-O 9350–9589) (C70–C72, D32–D33, 191–192/225)

Endocrine

Sellar:	Craniopharyngioma Pituicytoma

Other:	Pinealoma

CNS

Neuroepithelial
(brain tumors,
spinal tumors)

Glioma

Astrocyte	Astrocytoma Pilocytic astrocytoma Pleomorphic xanthoastrocytoma Subependymal giant cell astrocytoma Fibrillary astrocytoma Anaplastic astrocytoma Glioblastoma multiforme

Oligodendrocyte	Oligodendroglioma

Ependyma	Ependymoma Subependymoma

Choroid plexus	Choroid plexus tumor Choroid plexus papilloma Choroid plexus carcinoma

Multiple/unknown	Oligoastrocytoma Gliomatosis cerebri Gliosarcoma

Mature
neuron

PNET

Primitive

Medulloepithelioma

Meningiomas
(Meninges)

Hematopoietic

Primary central nervous system lymphoma

PNS: NST

Note: Not all brain tumors are of nervous tissue, and not all nervous tissue tumors are in the brain (see brain metastasis).

Index of the central nervous system

Description

Disease	Tests

Treatment	Drugs

Index of the peripheral nervous system

Description

Disease

Treatment

Tumors: endocrine gland neoplasia (C73–C75/D34–D35, 193–194/226–227)

Pancreas

Pituitary

Thyroid

Thyroid cancer (malignant): epithelial-cell carcinoma
- Papillary
- Follicular/Hurthle cell
Parafollicular cell
- Medullary
Anaplastic
Lymphoma
Squamous-cell carcinoma
Benign
- Thyroid adenoma
- Struma ovarii

Adrenal tumor

Parathyroid

Pineal gland

MEN

Index of hormones

Description	thyroid

Disease

Treatment	Drugs

Hematological malignancy/leukemia histology (ICD-O 9590–9989, C81–C96, 200–208)
Lymphoid/Lymphoproliferative, Lymphomas/Lymphoid leukemias (9590–9739, 9800–9839)

B cell
(lymphoma,
leukemia)
(most CD19

CD20)

By development/
marker

TdT+	ALL (Precursor B acute lymphoblastic leukemia/lymphoma)

CD5+	naive B cell (CLL/SLL) mantle zone (Mantle cell)

CD22+	Prolymphocytic CD11c+ (Hairy cell leukemia)

CD79a+	germinal center/follicular B cell (Follicular Burkitt's GCB DLBCL Primary cutaneous follicular lymphoma) marginal zone/marginal-zone B cell (Splenic marginal zone MALT Nodal marginal zone Primary cutaneous marginal zone lymphoma)

RS (CD15+, CD30+)	Classic Hodgkin's lymphoma (Nodular sclerosis) CD20+ (Nodular lymphocyte predominant Hodgkin's lymphoma)

PCDs/PP (CD38+/CD138+)	see

By infection

KSHV (Primary effusion)
EBV (Lymphomatoid granulomatosis
Post-transplant lymphoproliferative disorder)
HIV (AIDS-related lymphoma)
Helicobacter pylori (MALT lymphoma)

Cutaneous

T/NK

T cell
(lymphoma,
leukemia)
(most CD3

CD4
CD8)

By development/
marker

TdT+: ALL (Precursor T acute lymphoblastic leukemia/lymphoma)

prolymphocyte (Prolymphocytic)

Cutaneous

MF+variants	indolent: Mycosis fungoides Pagetoid reticulosis Granulomatous slack skin aggressive: Sézary disease Adult T-cell leukemia/lymphoma

Non-MF	CD30-: Non-mycosis fungoides CD30− cutaneous large T-cell lymphoma Pleomorphic T-cell lymphoma Lymphomatoid papulosis type B CD30+: CD30+ cutaneous T-cell lymphoma Secondary cutaneous CD30+ large cell lymphoma Lymphomatoid papulosis type A

Other peripheral

By infection

HTLV-1 (Adult T-cell leukemia/lymphoma)

NK cell/
(most CD56)

T or NK

Lymphoid+myeloid

Acute biphenotypic leukaemia

Lymphocytosis

Cutaneous lymphoid hyperplasia

Index of the immune system

Description

Disease

Treatment	Drugs

List of ICD-9 codes 140–239: neoplasms